Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal muscle physiology (HP:0011804)help
Parent Node:
expand
Functional motor deficit (HP:0004302)help
..Starting node
..expand
Exercise intolerance (HP:0003546)help
Term ID: 3546
Name: Exercise intolerance
Synonym: Decreased ability to exercise; Inability to exercise; Low exercise endurance; Poor exercise tolerance
Definition: A functional motor deficit where individuals whose responses to the challenges of exercise fail to achieve levels considered normal for their age and gender.
Comments:
Reference: HP:0003546
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandDifficulty climbing stairs (HP:0003551) help
..expandDifficulty running (HP:0009046) help
..expandDifficulty standing (HP:0003698) help
..expandDifficulty walking (HP:0002355) help
..expandEasy fatigability (HP:0003388) help
..expandFrequent falls (HP:0002359) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003546HP:0003546Exercise intolerance0ACAD9 CL E G H2897621497OMIM:611126Mitochondrial complex I deficiency due to acad9 deficiency.98
HP:0003546HP:0003546Exercise intolerance0ACTA1 CL E G H58129ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent96
HP:0003546HP:0003546Exercise intolerance0ACTC1 CL E G H70143ORPHA:99103Atrial septal defect, ostium secundum typeHP:0040282 - Frequent208
HP:0003546HP:0003546Exercise intolerance0AGK CL E G H5575021869OMIM:212350Sengers syndrome.82
HP:0003546HP:0003546Exercise intolerance0ALDH4A1 CL E G H8659406ORPHA:79101Hyperprolinemia type 2HP:0040282 - Frequent74
HP:0003546HP:0003546Exercise intolerance0ATP5F1D CL E G H513837OMIM:618120Mitochondrial complex V (atp synthase) deficiency, nuclear type 5.
HP:0003546HP:0003546Exercise intolerance0BCS1L CL E G H6171020OMIM:124000Mitochondrial complex III deficiency, nuclear type 1.72
HP:0003546HP:0003546Exercise intolerance0BICD2 CL E G H2329917208OMIM:615290Spinal muscular atrophy, lower extremity-predominant, 2, autosomaldominant46
HP:0003546HP:0003546Exercise intolerance0BVES CL E G H111491152OMIM:616812Muscular dystrophy, limb-girdle, autosomal recessive 25.2
HP:0003546HP:0003546Exercise intolerance0C1QBP CL E G H7081243OMIM:617713Combined oxidative phosphorylation deficiency 33.
HP:0003546HP:0003546Exercise intolerance0CAVIN1 CL E G H2841199688OMIM:613327Lipodystrophy, congenital generalized, type 4.48
HP:0003546HP:0003546Exercise intolerance0CCDC78 CL E G H12409314153OMIM:614807Myopathy, centronuclear, 425
HP:0003546HP:0003546Exercise intolerance0CHCHD10 CL E G H40091615559ORPHA:457050Autosomal dominant mitochondrial myopathy with exercise intoleranceHP:0040282 - Frequent11
HP:0003546HP:0003546Exercise intolerance0CHCHD10 CL E G H40091615559OMIM:616209Myopathy, isolated mitochondrial, autosomal dominant.11
HP:0003546HP:0003546Exercise intolerance0CITED2 CL E G H103701987ORPHA:99103Atrial septal defect, ostium secundum typeHP:0040282 - Frequent5
HP:0003546HP:0003546Exercise intolerance0CITED2 CL E G H103701987ORPHA:99105Atrial septal defect, sinus venosus typeHP:0040282 - Frequent5
HP:0003546HP:0003546Exercise intolerance0COA3 CL E G H2895824990OMIM:619058MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 14; MC4DN142
HP:0003546HP:0003546Exercise intolerance0COL12A1 CL E G H13032188ORPHA:536516Myopathic Ehlers-Danlos syndromeHP:0040283 - Occasional65
HP:0003546HP:0003546Exercise intolerance0COL13A1 CL E G H13052190OMIM:616720Myasthenic syndrome, congenital, 19.6
HP:0003546HP:0003546Exercise intolerance0COL9A1 CL E G H12972217ORPHA:166002Multiple epiphyseal dysplasia due to collagen 9 anomaly110
HP:0003546HP:0003546Exercise intolerance0COL9A2 CL E G H12982218ORPHA:166002Multiple epiphyseal dysplasia due to collagen 9 anomaly110
HP:0003546HP:0003546Exercise intolerance0COL9A3 CL E G H12992219ORPHA:166002Multiple epiphyseal dysplasia due to collagen 9 anomaly137
HP:0003546HP:0003546Exercise intolerance0COMP CL E G H13112227ORPHA:93308Multiple epiphyseal dysplasia type 189
HP:0003546HP:0003546Exercise intolerance0COQ8A CL E G H5699716812ORPHA:139485Autosomal recessive ataxia due to ubiquinone deficiencyHP:0040282 - Frequent136
HP:0003546HP:0003546Exercise intolerance0COQ8A CL E G H5699716812OMIM:612016Coenzyme Q10 deficiency, primary, 4.136
HP:0003546HP:0003546Exercise intolerance0COX1 CL E G H45127419ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0COX2 CL E G H45137421ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0COX3 CL E G H45147422ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0CPT2 CL E G H13762330ORPHA:228302Carnitine palmitoyl transferase II deficiency, myopathic formHP:0040281 - Very frequent101
HP:0003546HP:0003546Exercise intolerance0CPT2 CL E G H13762330ORPHA:228305Carnitine palmitoyl transferase II deficiency, severe infantile formHP:0040282 - Frequent101
HP:0003546HP:0003546Exercise intolerance0CYTB CL E G H45197427ORPHA:137675Histiocytoid cardiomyopathyHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0DMD CL E G H17562928ORPHA:98895Becker muscular dystrophyHP:0040281 - Very frequent1496
HP:0003546HP:0003546Exercise intolerance0DNA2 CL E G H17632939OMIM:615156Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal dominant, 6.41
HP:0003546HP:0003546Exercise intolerance0ENO3 CL E G H20273354OMIM:612932Glycogen storage disease XIII.34
HP:0003546HP:0003546Exercise intolerance0FARSA CL E G H21933592OMIM:619013RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2; RILDBC2
HP:0003546HP:0003546Exercise intolerance0FARSB CL E G H1005617800OMIM:613658Rajab interstitial lung disease with brain calcifications
HP:0003546HP:0003546Exercise intolerance0FLAD1 CL E G H8030824671OMIM:255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency.18
HP:0003546HP:0003546Exercise intolerance0GAA CL E G H25484065OMIM:232300Glycogen storage disease II407
HP:0003546HP:0003546Exercise intolerance0GATA4 CL E G H26264173ORPHA:99103Atrial septal defect, ostium secundum typeHP:0040282 - Frequent87
HP:0003546HP:0003546Exercise intolerance0GATA6 CL E G H26274174ORPHA:99103Atrial septal defect, ostium secundum typeHP:0040282 - Frequent37
HP:0003546HP:0003546Exercise intolerance0GCDH CL E G H26394189ORPHA:25Glutaryl-CoA dehydrogenase deficiencyHP:0040283 - Occasional115
HP:0003546HP:0003546Exercise intolerance0GMPPB CL E G H2992522932ORPHA:363623GMPPB-related limb-girdle muscular dystrophy R19HP:0040283 - Occasional34
HP:0003546HP:0003546Exercise intolerance0GMPPB CL E G H2992522932OMIM:615352Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14.34
HP:0003546HP:0003546Exercise intolerance0GYS1 CL E G H29974706OMIM:611556Glycogen storage disease 0, muscle52
HP:0003546HP:0003546Exercise intolerance0HADHA CL E G H30304801ORPHA:746Mitochondrial trifunctional protein deficiencyHP:0040281 - Very frequent99
HP:0003546HP:0003546Exercise intolerance0HADHB CL E G H30324803ORPHA:746Mitochondrial trifunctional protein deficiencyHP:0040281 - Very frequent60
HP:0003546HP:0003546Exercise intolerance0HINT1 CL E G H30944912ORPHA:324442Autosomal recessive axonal neuropathy with neuromyotoniaHP:0040282 - Frequent12
HP:0003546HP:0003546Exercise intolerance0ISCU CL E G H2347929882OMIM:255125Myopathy with exercise intolerance, Swedish type.19
HP:0003546HP:0003546Exercise intolerance0KBTBD13 CL E G H39059437227ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent80
HP:0003546HP:0003546Exercise intolerance0KBTBD13 CL E G H39059437227OMIM:609273Nemaline myopathy 6.80
HP:0003546HP:0003546Exercise intolerance0KCNE1 CL E G H37536240ORPHA:90647Jervell and Lange-Nielsen syndrome148
HP:0003546HP:0003546Exercise intolerance0KCNQ1 CL E G H37846294ORPHA:90647Jervell and Lange-Nielsen syndrome730
HP:0003546HP:0003546Exercise intolerance0KLHL41 CL E G H1032416905ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent13
HP:0003546HP:0003546Exercise intolerance0LAMP2 CL E G H39206501OMIM:300257Danon disease.211
HP:0003546HP:0003546Exercise intolerance0LDHA CL E G H39396535OMIM:612933Glycogen storage disease XI.35
HP:0003546HP:0003546Exercise intolerance0MGME1 CL E G H9266716205OMIM:615084Mitochondrial DNA depletion syndrome 11.11
HP:0003546HP:0003546Exercise intolerance0MGME1 CL E G H9266716205ORPHA:352447Progressive external ophthalmoplegia-myopathy-emaciation syndromeHP:0040282 - Frequent11
HP:0003546HP:0003546Exercise intolerance0MIEF2 CL E G H12517017920OMIM:619024COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 49; COXPD49
HP:0003546HP:0003546Exercise intolerance0MLIP CL E G H9052321355OMIM:620138
HP:0003546HP:0003546Exercise intolerance0MRPS2 CL E G H5111614495OMIM:617950Combined oxidative phosphorylation deficiency 36
HP:0003546HP:0003546Exercise intolerance0MYH6 CL E G H46247576ORPHA:99103Atrial septal defect, ostium secundum typeHP:0040282 - Frequent452
HP:0003546HP:0003546Exercise intolerance0MYPN CL E G H8466523246ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent217
HP:0003546HP:0003546Exercise intolerance0ND1 CL E G H45357455ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0ND4 CL E G H45387459ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0ND5 CL E G H45407461ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0ND6 CL E G H45417462ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0NDUFS4 CL E G H47247711OMIM:252010Mitochondrial complex I deficiency, nuclear type 1.27
HP:0003546HP:0003546Exercise intolerance0NEB CL E G H47037720ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent745
HP:0003546HP:0003546Exercise intolerance0NKX2-5 CL E G H14822488ORPHA:99103Atrial septal defect, ostium secundum typeHP:0040282 - Frequent90
HP:0003546HP:0003546Exercise intolerance0NPPA CL E G H48787939ORPHA:1344Atrial standstill13
HP:0003546HP:0003546Exercise intolerance0PFKM CL E G H52138877OMIM:232800Glycogen storage disease VII.64
HP:0003546HP:0003546Exercise intolerance0PGAM2 CL E G H52248889OMIM:261670Phosphoglycerate mutase, muscle, deficiency of.26
HP:0003546HP:0003546Exercise intolerance0PGK1 CL E G H52308896OMIM:300653Phosphoglycerate kinase 1 deficiency.21
HP:0003546HP:0003546Exercise intolerance0PGM1 CL E G H52368905OMIM:614921Congenital disorder of glycosylation, type It58
HP:0003546HP:0003546Exercise intolerance0PHKA1 CL E G H52558925OMIM:300559Muscle glycogenosis, X-linked.54
HP:0003546HP:0003546Exercise intolerance0PHKA2 CL E G H52568926ORPHA:264580Glycogen storage disease due to liver phosphorylase kinase deficiencyHP:0040283 - Occasional54
HP:0003546HP:0003546Exercise intolerance0PHKB CL E G H52578927ORPHA:79240Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency101
HP:0003546HP:0003546Exercise intolerance0PHKG2 CL E G H52618931ORPHA:264580Glycogen storage disease due to liver phosphorylase kinase deficiencyHP:0040283 - Occasional48
HP:0003546HP:0003546Exercise intolerance0PNPLA2 CL E G H5710430802OMIM:610717Neutral lipid storage disease with myopathy65
HP:0003546HP:0003546Exercise intolerance0POLG CL E G H54289179ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040282 - Frequent464
HP:0003546HP:0003546Exercise intolerance0POLG CL E G H54289179ORPHA:254886Autosomal recessive progressive external ophthalmoplegiaHP:0040283 - Occasional464
HP:0003546HP:0003546Exercise intolerance0POLG CL E G H54289179OMIM:157640Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1.464
HP:0003546HP:0003546Exercise intolerance0POLG CL E G H54289179OMIM:258450Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessive.464
HP:0003546HP:0003546Exercise intolerance0POLG CL E G H54289179OMIM:607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis464
HP:0003546HP:0003546Exercise intolerance0POLG2 CL E G H112329180ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040282 - Frequent45
HP:0003546HP:0003546Exercise intolerance0POLG2 CL E G H112329180OMIM:610131Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4.45
HP:0003546HP:0003546Exercise intolerance0POLR2A CL E G H54309187OMIM:618603NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES; NEDHIB
HP:0003546HP:0003546Exercise intolerance0PUS1 CL E G H8032415508OMIM:600462Myopathy, lactic acidosis, and sideroblastic anemia 1.57
HP:0003546HP:0003546Exercise intolerance0PYGL CL E G H58369725ORPHA:369Glycogen storage disease due to liver glycogen phosphorylase deficiency71
HP:0003546HP:0003546Exercise intolerance0PYGM CL E G H58379726ORPHA:368Glycogen storage disease due to muscle glycogen phosphorylase deficiencyHP:0040281 - Very frequent166
HP:0003546HP:0003546Exercise intolerance0PYGM CL E G H58379726OMIM:232600Glycogen storage disease V166
HP:0003546HP:0003546Exercise intolerance0RNASEH1 CL E G H24624318466ORPHA:329336Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathyHP:0040281 - Very frequent3
HP:0003546HP:0003546Exercise intolerance0RNASEH1 CL E G H24624318466OMIM:616479Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2.3
HP:0003546HP:0003546Exercise intolerance0RRM2B CL E G H5048417296ORPHA:329336Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathyHP:0040281 - Very frequent125
HP:0003546HP:0003546Exercise intolerance0RRM2B CL E G H5048417296ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040282 - Frequent125
HP:0003546HP:0003546Exercise intolerance0RRM2B CL E G H5048417296OMIM:613077Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5.125
HP:0003546HP:0003546Exercise intolerance0RSPH4A CL E G H34589521558OMIM:612649Ciliary dyskinesia, primary, 11.58
HP:0003546HP:0003546Exercise intolerance0RSPH9 CL E G H22142121057OMIM:612650CILIARY DYSKINESIA, PRIMARY, 12; CILD1220
HP:0003546HP:0003546Exercise intolerance0SCN5A CL E G H633110593ORPHA:1344Atrial standstill1134
HP:0003546HP:0003546Exercise intolerance0SDHA CL E G H638910680OMIM:252011Mitochondrial complex II deficiency.304
HP:0003546HP:0003546Exercise intolerance0SLC18A3 CL E G H657210936OMIM:617239Myasthenic syndrome, congenital, 21, presynaptic.2
HP:0003546HP:0003546Exercise intolerance0SLC22A12 CL E G H11608517989ORPHA:94088Hereditary renal hypouricemia56
HP:0003546HP:0003546Exercise intolerance0SLC25A32 CL E G H8103429683OMIM:616839EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE; RREI3
HP:0003546HP:0003546Exercise intolerance0SLC25A4 CL E G H29110990ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040282 - Frequent68
HP:0003546HP:0003546Exercise intolerance0SLC25A4 CL E G H29110990OMIM:615418Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type).68
HP:0003546HP:0003546Exercise intolerance0SLC25A4 CL E G H29110990OMIM:609283Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2.68
HP:0003546HP:0003546Exercise intolerance0SLC2A9 CL E G H5660613446ORPHA:94088Hereditary renal hypouricemia57
HP:0003546HP:0003546Exercise intolerance0SURF1 CL E G H683411474OMIM:220110Mitochondrial complex IV deficiency.73
HP:0003546HP:0003546Exercise intolerance0SVIL CL E G H684011480OMIM:619040MYOFIBRILLAR MYOPATHY 10; MFM101
HP:0003546HP:0003546Exercise intolerance0TAFAZZIN CL E G H690111577OMIM:302060Barth syndrome.
HP:0003546HP:0003546Exercise intolerance0TBX20 CL E G H5705711598ORPHA:99103Atrial septal defect, ostium secundum typeHP:0040282 - Frequent20
HP:0003546HP:0003546Exercise intolerance0TK2 CL E G H708411831ORPHA:254886Autosomal recessive progressive external ophthalmoplegiaHP:0040283 - Occasional103
HP:0003546HP:0003546Exercise intolerance0TK2 CL E G H708411831ORPHA:254875Mitochondrial DNA depletion syndrome, myopathic formHP:0040282 - Frequent103
HP:0003546HP:0003546Exercise intolerance0TLL1 CL E G H709211843ORPHA:99106Atrial septal defect, ostium primum typeHP:0040283 - Occasional6
HP:0003546HP:0003546Exercise intolerance0TLL1 CL E G H709211843ORPHA:99103Atrial septal defect, ostium secundum typeHP:0040282 - Frequent6
HP:0003546HP:0003546Exercise intolerance0TMEM126B CL E G H5586330883OMIM:618250Mitochondrial complex I deficiency, nuclear type 29.4
HP:0003546HP:0003546Exercise intolerance0TOP3A CL E G H715611992OMIM:618098Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5.
HP:0003546HP:0003546Exercise intolerance0TPM2 CL E G H716912011ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent54
HP:0003546HP:0003546Exercise intolerance0TPM3 CL E G H717012012ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent108
HP:0003546HP:0003546Exercise intolerance0TRMT5 CL E G H5757023141OMIM:616539Combined oxidative phosphorylation deficiency 26.4
HP:0003546HP:0003546Exercise intolerance0TRNE CL E G H45567479ORPHA:2596Myopathy and diabetes mellitusHP:0040282 - Frequent
HP:0003546HP:0003546Exercise intolerance0TRNF CL E G H45587481ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0TRNH CL E G H45647487ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0TRNK CL E G H45667489ORPHA:1349Mitochondrial DNA-related cardiomyopathy and hearing lossHP:0040282 - Frequent
HP:0003546HP:0003546Exercise intolerance0TRNL1 CL E G H45677490ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0TRNN CL E G H45707493OMIM:220110Mitochondrial complex IV deficiency.
HP:0003546HP:0003546Exercise intolerance0TRNQ CL E G H45727495ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0TRNS1 CL E G H45747497ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0TRNS1 CL E G H45747497OMIM:220110Mitochondrial complex IV deficiency.
HP:0003546HP:0003546Exercise intolerance0TRNS2 CL E G H45757498ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0TRNW CL E G H45787501ORPHA:550MELASHP:0040283 - Occasional
HP:0003546HP:0003546Exercise intolerance0TWNK CL E G H566521160ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040282 - Frequent113
HP:0003546HP:0003546Exercise intolerance0TWNK CL E G H566521160OMIM:609286Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3.113
HP:0003546HP:0003546Exercise intolerance0TWNK CL E G H566521160OMIM:607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis113
HP:0003546HP:0003546Exercise intolerance0YARS2 CL E G H5106724249OMIM:613561Myopathy, lactic acidosis, and sideroblastic anemia 2.45
HP:0003546HP:0030973Postexertional symptom exacerbation1BICD2 CL E G H2329917208OMIM:615290Spinal muscular atrophy, lower extremity-predominant, 2, autosomaldominant46
HP:0003546HP:0030973Postexertional symptom exacerbation1COL9A1 CL E G H12972217ORPHA:166002Multiple epiphyseal dysplasia due to collagen 9 anomalyHP:0040282 - Frequent110
HP:0003546HP:0030973Postexertional symptom exacerbation1COL9A2 CL E G H12982218ORPHA:166002Multiple epiphyseal dysplasia due to collagen 9 anomalyHP:0040282 - Frequent110
HP:0003546HP:0030973Postexertional symptom exacerbation1COL9A3 CL E G H12992219ORPHA:166002Multiple epiphyseal dysplasia due to collagen 9 anomalyHP:0040282 - Frequent137
HP:0003546HP:0030973Postexertional symptom exacerbation1COMP CL E G H13112227ORPHA:93308Multiple epiphyseal dysplasia type 1HP:0040282 - Frequent89
HP:0003546HP:0030973Postexertional symptom exacerbation1KCNE1 CL E G H37536240ORPHA:90647Jervell and Lange-Nielsen syndromeHP:0040282 - Frequent148
HP:0003546HP:0030973Postexertional symptom exacerbation1KCNQ1 CL E G H37846294ORPHA:90647Jervell and Lange-Nielsen syndromeHP:0040282 - Frequent730
HP:0003546HP:0030973Postexertional symptom exacerbation1NPPA CL E G H48787939ORPHA:1344Atrial standstillHP:0040282 - Frequent13
HP:0003546HP:0030973Postexertional symptom exacerbation1PYGL CL E G H58369725ORPHA:369Glycogen storage disease due to liver glycogen phosphorylase deficiencyHP:0040283 - Occasional71
HP:0003546HP:0030973Postexertional symptom exacerbation1PYGM CL E G H58379726ORPHA:368Glycogen storage disease due to muscle glycogen phosphorylase deficiencyHP:0040283 - Occasional166
HP:0003546HP:0030973Postexertional symptom exacerbation1SCN5A CL E G H633110593ORPHA:1344Atrial standstillHP:0040282 - Frequent1134
HP:0003546HP:0030973Postexertional symptom exacerbation1SLC22A12 CL E G H11608517989ORPHA:94088Hereditary renal hypouricemiaHP:0040281 - Very frequent56
HP:0003546HP:0030973Postexertional symptom exacerbation1SLC2A9 CL E G H5660613446ORPHA:94088Hereditary renal hypouricemiaHP:0040281 - Very frequent57
HP:0003546HP:0030973Postexertional symptom exacerbation1SVIL CL E G H684011480OMIM:619040MYOFIBRILLAR MYOPATHY 10; MFM101


Genes (112) :ACAD9 ACTA1 ACTC1 AGK ALDH4A1 ATP5F1D BCS1L BICD2 BVES C1QBP CAVIN1 CCDC78 CHCHD10 CITED2 COA3 COL12A1 COL13A1 COL9A1 COL9A2 COL9A3 COMP COQ8A COX1 COX2 COX3 CPT2 CYTB DMD DNA2 ENO3 FARSA FARSB FLAD1 GAA GATA4 GATA6 GCDH GMPPB GYS1 HADHA HADHB HINT1 ISCU KBTBD13 KCNE1 KCNQ1 KLHL41 LAMP2 LDHA MGME1 MIEF2 MLIP MRPS2 MYH6 MYPN ND1 ND4 ND5 ND6 NDUFS4 NEB NKX2-5 NPPA PFKM PGAM2 PGK1 PGM1 PHKA1 PHKA2 PHKB PHKG2 PNPLA2 POLG POLG2 POLR2A PUS1 PYGL PYGM RNASEH1 RRM2B RSPH4A RSPH9 SCN5A SDHA SLC18A3 SLC22A12 SLC25A32 SLC25A4 SLC2A9 SURF1 SVIL TAFAZZIN TBX20 TK2 TLL1 TMEM126B TOP3A TPM2 TPM3 TRMT5 TRNE TRNF TRNH TRNK TRNL1 TRNN TRNQ TRNS1 TRNS2 TRNW TWNK YARS2

Diseases (93) :OMIM:611126 ORPHA:171439 ORPHA:99103 OMIM:212350 ORPHA:79101 OMIM:618120 OMIM:124000 OMIM:615290 OMIM:616812 OMIM:617713 OMIM:613327 OMIM:614807 ORPHA:457050 OMIM:616209 ORPHA:99105 OMIM:619058 ORPHA:536516 OMIM:616720 ORPHA:166002 ORPHA:93308 ORPHA:139485 OMIM:612016 ORPHA:550 ORPHA:228302 ORPHA:228305 ORPHA:137675 ORPHA:98895 OMIM:615156 OMIM:612932 OMIM:619013 OMIM:613658 OMIM:255100 OMIM:232300 ORPHA:25 ORPHA:363623 OMIM:615352 OMIM:611556 ORPHA:746 ORPHA:324442 OMIM:255125 OMIM:609273 ORPHA:90647 OMIM:300257 OMIM:612933 OMIM:615084 ORPHA:352447 OMIM:619024 OMIM:620138 OMIM:617950 OMIM:252010 ORPHA:1344 OMIM:232800 OMIM:261670 OMIM:300653 OMIM:614921 OMIM:300559 ORPHA:264580 ORPHA:79240 OMIM:610717 ORPHA:254892 ORPHA:254886 OMIM:157640 OMIM:258450 OMIM:607459 OMIM:610131 OMIM:618603 OMIM:600462 ORPHA:369 ORPHA:368 OMIM:232600 ORPHA:329336 OMIM:616479 OMIM:613077 OMIM:612649 OMIM:612650 OMIM:252011 OMIM:617239 ORPHA:94088 OMIM:616839 OMIM:615418 OMIM:609283 OMIM:220110 OMIM:619040 OMIM:302060 ORPHA:254875 ORPHA:99106 OMIM:618250 OMIM:618098 OMIM:616539 ORPHA:2596 ORPHA:1349 OMIM:609286 OMIM:613561
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.